Breakthrough seizure following substitution of Depakene capsules (Abbott) with a generic product.

Breakthrough seizure following substitution of Depakene capsules (Abbott) with a generic product.

Item
http://www.wikidata.org/entity/Q34166670
Generic versus branded antiepileptic drug monotherapy for epilepsyUnderstanding patients' perspective in the use of generic antiepileptic drugs: compelling lessons for physicians to improve physician/patient communication.Refilling and switching of antiepileptic drugs and seizure-related eventsRecommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs.Substitution of anticonvulsant drugs.Paroxetine mesylate: comparable to paroxetine hydrochloride?Generic substitution of antiepileptic drugs.Switching from brand-name to generic psychotropic medications: a literature review.Comparative bioavailability of a generic phenytoin and Dilantin.[Changing lamotrigine preparations in epilepsy patients. Experiences of a university epilepsy outpatient centre].Comparison of steady-state blood levels of two carbamazepine formulations.Case-control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes.Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes
P2860

Breakthrough seizure following substitution of Depakene capsules (Abbott) with a generic product.

Item
http://www.wikidata.org/entity/Q34166670
description
1987 nî lūn-bûn
@nan
1987 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Breakthrough seizure following ...... bbott) with a generic product.
@ast
Breakthrough seizure following ...... bbott) with a generic product.
@en
Breakthrough seizure following substitution of Depakene capsules
@nl
type
label
Breakthrough seizure following ...... bbott) with a generic product.
@ast
Breakthrough seizure following ...... bbott) with a generic product.
@en
Breakthrough seizure following substitution of Depakene capsules
@nl
prefLabel
Breakthrough seizure following ...... bbott) with a generic product.
@ast
Breakthrough seizure following ...... bbott) with a generic product.
@en
Breakthrough seizure following substitution of Depakene capsules
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Breakthrough seizure following ...... bbott) with a generic product.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698